Heterologous Expression and Antimicrobial Targets of a Novel Glycine-Rich Antimicrobial Peptide from Artemia franciscana

The growing problem of antimicrobial resistance in aquaculture, caused by the excessive and unregulated use of antibiotics, highlights the critical necessity for developing new anti-infective solutions. Based on the characteristics of glycine-rich antimicrobial peptides (AMPs) and transcriptomic data, an antimicrobial peptide, namely <i>Af</i>Rgly1, was discovered in this study. Subsequently, the peptide was obtained through heterologous expression in <i>E. coli</i>, and its antibacterial spectrum was determined. Molecular dynamics simulation and molecular biology experiments were conducted to explore the antibacterial target of <i>Af</i>Rgly1. Results showed that the mRNA expression level of <i>Af</i>Rgly1 was significantly upregulated after <i>Vibrio alginolyticus</i> infection. <i>Af</i>Rgly1 has broad-spectrum antibacterial activity targeting on bacterial cell membrane, and it may also interact with bacterial DNA. <i>Af</i>Rgly1 displayed low selectivity for fish red blood cells. These results indicate that <i>Af</i>Rgly1 is an antimicrobial peptide with considerable potential for application in the development of therapeutic agents.

Authors

Institutions

Publication Details

Journal
Marine Drugs
Published
2025-08-17
DOI
https://doi.org/10.3390/md23080330
Citations
1
Primary Topic
Antimicrobial Peptides and Activities
Type
article
Field-Weighted Citation Impact
1.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Heterologous Expression and Antimicrobial Targets of a Novel Glycine-Rich Antimicrobial Peptide from Artemia franciscana

Huaiyuan Ye, Guangming Yu, Ming Tao, D. Chen et al.
1 citations
Marine Drugs
Antimicrobial Peptides and Activities
1.18
article

Heterologous Expression and Antimicrobial Targets of a Novel Glycine-Rich Antimicrobial Peptide from Artemia franciscana

Huaiyuan Ye, Guangming Yu, Ming Tao, D. Chen, Wei Zhang, Aobo Sun, Hongwei Shao
article en
1 citations

Abstract

The growing problem of antimicrobial resistance in aquaculture, caused by the excessive and unregulated use of antibiotics, highlights the critical necessity for developing new anti-infective solutions. Based on the characteristics of glycine-rich antimicrobial peptides (AMPs) and transcriptomic data, an antimicrobial peptide, namely <i>Af</i>Rgly1, was discovered in this study. Subsequently, the peptide was obtained through heterologous expression in <i>E. coli</i>, and its antibacterial spectrum was determined. Molecular dynamics simulation and molecular biology experiments were conducted to explore the antibacterial target of <i>Af</i>Rgly1. Results showed that the mRNA expression level of <i>Af</i>Rgly1 was significantly upregulated after <i>Vibrio alginolyticus</i> infection. <i>Af</i>Rgly1 has broad-spectrum antibacterial activity targeting on bacterial cell membrane, and it may also interact with bacterial DNA. <i>Af</i>Rgly1 displayed low selectivity for fish red blood cells. These results indicate that <i>Af</i>Rgly1 is an antimicrobial peptide with considerable potential for application in the development of therapeutic agents.

Marine DrugsVol. 23(8)
Shenzhen University (CN), Beibu Gulf University (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 18%
Antimicrobial Peptides and Activities
1.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Heterologous Expression and Antimicrobial Targets of a Novel Glycine-Rich Antimicrobial Peptide from Artemia franciscana — Huaiyuan Ye, Guangming Yu, et al. · Marine Drugs (2025) | TGRS Research Map | TGRS